ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3%
Thu, 23 Jan

ALEMBIC PHARMA has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:

ALEMBIC PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-18*
3
Sep-19*
3
Dec-19*
QoQ ChangeYoY Change
Net SalesRs m10,18212,40912,091-2.6%18.8%
Other incomeRs m354413.3%-88.4%
TurnoverRs m10,21712,41212,095-2.6%18.4%
ExpensesRs m7,7598,9548,841-1.3%13.9%
Gross profitRs m2,4223,4553,251-5.9%34.2%
DepreciationRs m29136041816.3%44.0%
InterestRs m6071744.1%23.8%
Profit before taxRs m2,1083,0292,763-8.8%31.1%
TaxRs m400525486-7.4%21.5%
Profit after taxRs m1,7082,5042,277-9.1%33.3%
Gross profit margin%23.827.826.9
Effective tax rate%19.017.317.6
Net profit margin%16.720.218.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 18.8% on a year-on-year (YoY) basis. The expenses were up by 13.9% YoY during the same period.
  • The company's operating profit increased by 34.2% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 26.9% in 3QFY20 as against 23.8% in 3QFY19.
  • Depreciation charges increased by 44.0% and finance costs increased by 23.8% YoY, respectively.
  • Other income declined by 88.4% YoY during the quarter.
  • Net profit for the quarter increased by 33.3% YoY. Net profit margins during the quarter increased from 16.7% in 3QFY19 to 18.8% in 3QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 2.6% on a quarter-on-quarter (QoQ) basis. The expenses were down by 1.3% QoQ during the same period.
  • The company's operating profit declined by 5.9% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 26.9% in 3QFY20 as against 27.8% in 2QFY19.
  • Net profit for the quarter declined by 9.1% QoQ, while net profit margins declined from 20.2% in 2QFY19 to 18.8% in 3QFY20.

To see how ALEMBIC PHARMA has performed over the last eight quarters,please visit here.

Free Signup: The Smallcap Fortunes Summit

ALEMBIC PHARMA Share Price Performance

Over the last one year,ALEMBIC PHARMA share price has moved down from Rs 592.0 to Rs 587.0, registering a Loss of Rs 5.0 or around 0.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,048.8 (up 0.3%). Over the last one year it has moved down from 14,066.6 to 14,048.8, a gain of 18 points (down 0.1%).

Overall, the S&P BSE SENSEX is up 13.4% over the year.

Current Valuations

At the current price of Rs 587.0, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 15.1 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.1 times.

Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3%". Click here!

  

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Mar 2, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS